  We propose a disease classification model, called the QC-SPHARM, for the
early detection of the Alzheimer's Disease (AD). The proposed QC-SPHARM can
distinguish between normal control (NC) subjects and AD patients, as well as
between amnestic mild cognitive impairment (aMCI) patients having high
possibility progressing into AD and those who do not. Using the spherical
harmonics (SPHARM) based registration, hippocampal surfaces segmented from the
ADNI data are individually registered to a template surface constructed from
the NC subjects using SPHARM. Local geometric distortions of the deformation
from the template surface to each subject are quantified in terms of
conformality distortions and curvatures distortions. The measurements are
combined with the spherical harmonics coefficients and the total volume change
of the subject from the template. Afterwards, a t-test based feature selection
method incorporating the bagging strategy is applied to extract those local
regions having high discriminating power of the two classes. The disease
diagnosis machine can therefore be built using the data under the Support
Vector Machine (SVM) setting. Using 110 NC subjects and 110 AD patients from
the ADNI database, the proposed algorithm achieves 85:2% testing accuracy on 80
random samples as testing subjects, with the incorporation of surface geometry
in the classification machine. Using 20 aMCI patients who has advanced to AD
during a two-year period and another 20 aMCI patients who remain non-AD for the
next two years, the algorithm achieves 81:2% accuracy using 10 randomly picked
subjects as testing data. Our proposed method is 6%-15% better than other
classification models without the incorporation of surface geometry. The
results demonstrate the advantages of using local geometric distortions as the
discriminating criterion for early AD diagnosis.
